Healthcare Judicialization: CMED opens Public Consultation on pricing rules for Government purchases

On January 8, 2026, the Brazilian Drug Market Regulation Chamber (CMED) published in the Federal Register the Public Consultation No. 1/2026, which aims to gather contributions from civil society and the regulated sector on criteria for setting and adjusting prices of medicines sold to government entities to comply with court-ordered demands. The regulation of this matter stems from a determination by the Federal Supreme Court under Theme 1234.

The deadline for submitting contributions is 60 days and will end on March 9, 2026.

The draft resolution and other supporting documents can be accessed through this link.

The Life Sciences & Healthcare team at Souto Correa Advogados is available to answer any questions regarding the proposed resolution via email: lifesciences@soutocorrea.com.br.